Carol Fabian inducted into KU Women’s Hall of Fame for contributions to breast cancer research

19 May
Carol Fabian inducted into KU Women's Hall of Fame for contributions to breast cancer research

Among the women inducted into the University of Kansas Hall of Fame on April 14, 2016, was Carol Fabian, MD. Fabian, a professor of medicine at the University of Kansas Medical Center and director of the Breast Cancer Prevention Center … Read More »

Early Stage II Testicular Cancer: Radiotherapy more better than Chemotherapy?

10 May
Early Stage II Testicular Cancer: Radiotherapy more better than Chemotherapy?

A large study on testicular cancer shows early stage for those simplified testicular seminoma patients with stage II cells, the therapeutic effect of radiotherapy is superior to chemotherapy. Early stage II testicular cancer that has not yet appeared distant metastases, … Read More »

The Researchers Designed a Method to Stabilize the Internal Chemotherapy Loaded Into the Micro Prostate Cells

29 Apr

A collaborative Brigham and Women’s Hospital (BWH) and Johns Hopkins University (JHU) co-led team has found proof-of-concept evidence for a potential cancer treatment that leverages microparticles and mesenchymal stem cells. The researchers devised an approach to stably internalize chemotherapy loaded … Read More »

Researchers Launch Clinical Trials to Test Novel Cellular-immunotherapy to Treat Three Types of Blood Cancer

27 Feb
In medicine, cancer refers to a malignant tumor derived from epithelial tissue, cancer is the most common type

In medicine, cancer refers to a malignant tumor derived from epithelial tissue, cancer is the most common type. Cancer immunology is based upon boosting the body’s own immune system to vanquish malignancies. It is among the fastest growing areas of … Read More »

Breast cancer patients treated with anthracycline-based chemotherapy regimens may be at greater risk of neurocognitive problems than those given nonanthracycline regimens

7 Dec
Breast cancer patients treated with anthracycline-based chemotherapy regimens may be at greater risk of neurocognitive problems than those given nonanthracycline regimens

A meta-analysis of Laurentiis De, Italy, to compare the DFS and overall survival of patients with high risk of early breast cancer, compared with the addition of paclitaxel in the treatment of patients with an early stage of the disease. … Read More »